Exosome injection safety checked in small study
NCT ID NCT06429033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether a purified exosome product (PEP) is safe when injected into the skin of healthy adults. Eight participants received the injection and were monitored for side effects. The goal was to check for any immediate reactions or lab changes, not to treat a disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Testing of Beverly Hills
Encino, California, 91436, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a two-drug combo better tame prostate trouble?
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Tiny study checks if novel bacterium is safe for people
- New painkiller oliceridine tested against morphine in back surgery patients
- New online guide aids dementia caregivers in tough gun safety choices
- New supplement shows promise for stress and sleep in healthy adults